Navigation Links
Researchers see ethical dilemmas of providing care in drug detention centers
Date:11/10/2010

(Garrison, NY) Organizations that seek to provide health care, food, and other services to people held in drug detention centers in developing countries often face ethical dilemmas: Are they doing more good than harm? Are they helping detainees or legitimizing a corrupt system and ultimately building its capacity to detain and abuse more people?

Such dilemmas are explored in an article coauthored by Nancy Berlinger and Michael Gusmano, research scholars at The Hastings Center, along with Roxanne Saucier and Daniel Wolfe of the Open Society Institute, and Nicholas Thomson of Johns Hopkins Bloomberg School of Public Health. The article appears in the current issue of the International Journal of Prisoner Health.

The article focuses on the drug detention centers that have proliferated over the last decade in China, Cambodia, Vietnam, and other parts of Asia. Although the centers say that they provide drug treatment and rehabilitation, in reality people inside receive no effective drug treatment, little medical care, and insufficient food. Indeed, they are more likely to face what amounts to torture, cruel, inhuman, and degrading treatment. Unlike prisons, detention centers have no judicial process or right of appeal. More than 400,000 people are detained each year.

Some nongovernmental organizations attempt to provide care and services to the detainees, but center administrators and their governments sometimes seek these relationships to legitimatize the detention centers. "In 2008, many were alarmed when a large U.S.-funded health organization sent an announcement saying that they were going to help make a notoriously abusive drug detention center in Cambodia a 'Center for Excellence,'" the authors write. "This same center was widely viewed by most health and human rights organizations as beyond redemption."

The goal of providing health services to detainees is ethically sound, the article says. However, it presents an ethical dilemma a situation in which no option is clearly right, and that can be resolved only by determining which option is less wrong than others under particular circumstances. "It would be incorrect to assume that doing something in this setting in this case, undertaking health-related goals is better than doing 'nothing,'" the authors write. Doing nothing may be preferable if engaging with drug detention centers amounts to what the authors call a "rotten compromise."

They conclude that leaders of health-related organizations should evaluate how their programs can promote health in drug detention centers, and also how or whether their work might make conditions much worse. Given that health-related resources are limited, the authors suggest that the leaders ask themselves, "might the resources in this instance be better served by efforts to keep individuals out of detention centers in the first instance?"


'/>"/>

Contact: Michael Turton
turtonm@thehastingscenter.org
845-424-4040 x242
The Hastings Center
Source:Eurekalert

Related medicine news :

1. Circuit regulating anti-diabetic actions of serotonin uncovered by UT Southwestern researchers
2. U of M researchers find learning in the visual brain
3. Researchers discover important link between adrenal gland hormone and brain in hypertension
4. Hebrew University researchers discover expanded role for cancer-causing gene
5. Researchers expand cyberspace to fight chronic condition in breast cancer survivors
6. Researchers led by St. Michaels Hospital receive grant to teach new method of CPR
7. Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodes
8. Mayo researchers find mortality rates from liver diseases underestimated
9. Inhaled steroids increase diabetes risk, say Lady Davis Institute researchers
10. Researchers develop successful method for extracting and archiving patient radiation dose info
11. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... A recent report from the Wisconsin ... the 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools ... in student test score performance, the report’s limited analyses fail to provide answers ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
(Date:4/24/2017)... Nashville, TN (PRWEB) , ... April 24, 2017 , ... ... electrifying fans and transforming the quarterback position. The former overall number one pick in ... his professional football career. He holds the record for the most career rushing yards ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: